Published Date: 15 May 2023
If vitamin D is taken daily, it may lower cancer mortality in the population by 12%. This was the outcome of an.
Read Full NewsAlmost immediately after Theresa Greco was diagnosed with breast cancer in March, doctors asked her whether she wanted to participate in a clinical trial. The trial would do high-powered radiation targeted at her tumor prior ...
Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting the protein essential to tumor cell growth and by adding a key signal to boost the immune system response. ...
Indoor hydroponic gardening—a method of growing plants using nutrient-rich water instead of soil—could help cancer patients develop better mental health, eat a healthier diet and enjoy a better overall quality of life.
In the United States, the incarcerated population is aging. About 15% of incarcerated adults, or approximately 175,000 people, are now 55 years or older.
1.
A Possible Novel CAR-T Treatment for High-Risk R/R Follicular Lymphoma May Be Liso-Cel.
2.
Higher Binge Drinking Rates Linked to New Cannabis Laws.
3.
Sports for girls are frequently abandoned due to uniform issues.
4.
MCh in Surgical Oncology: Admission, Medical School, Fees, Qualifications Information
5.
Benzene in Cold Med; Male Cancer Death to Rise 93%; Mail-Order Drugs Compromised?
1.
Gut microbiota in curing cancer
2.
Cardio-Oncology in Survivors: Safeguarding Hearts Through Multidisciplinary Care
3.
Understanding the Importance of CA125: A Comprehensive Guide
4.
Hemophilia: Pathophysiology, Genetics, and Treatment Advances
5.
Unlocking the Secrets of Blood Production: The Journey and Regulation of Hematopoietic Stem Cells
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
2.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation